• Be A Partner
  • Social Responsibility
    • Students Training
  • IR
    • Investor Relations
    • Financial Charts
    • Annual Reports
  • News
    • PRESS RELEASES
    • SOCIAL EVENTS
    • CONFERENCES
  • Careers
  • Covid-19
  • Report a side effect
  • Contact Us
    • Branches
  • Home
  • We are Eipico
    We are Eipico
    EIPICO was established in Tenth of Ramadan City in 1980, with a capital of EGP 7 Million.
    • Uniqueness
      • WHO Approval
      • Sterile products Area
      • Automatic Ampoules Inspection
      • Eipico Ophthalmology
      • Primary packaging materials
      • Restricted-access barrier system
      • Distribution Channel
    • Our History
    • Vision, Mission & Values
    • Chairman Message
    • Eipico Employees
    • Manufacturing Facilities
    • Media Library
  • Global
    Global
    EIPICO is ranked Number 1 in Egyptian Exports of Pharmaceutical Products, capturing 29% of Egypt’s Total Exports of Pharmaceutical Products, by Value.
    • Eipico Destination
  • Manufacturing Facilities
    Manufacturing Facilities
    EIPICO is the Leading Egyptian Pharmaceutical Company, in Production, by Units. It is the Major Provider of Antibiotics, Lyophilized products and Spansule Capsules, to the Egyptian market.
    • Factory 1
    • Factory 2
    • Factory 3 (Biotechnology)
    • Eiaco Factory
    • Batterjee Factory
    • EIPICO Plastic Factory
  • R&D And Quality
    R&D And Quality
    EIPICO provides High Quality Pharmaceutical Products at reasonable prices, thus assisting human healthcare improvement .
    • Quality Assurance
    • Quality Control
    • R&D
    • Regulatory Affairs
    • Global Accreditation
    • Track and Trace
  • Products
    Products
    EIPICO produces 400 Pharmaceutical Products covering 25 therapeutic classes and it is the Major Provider of Antibiotics, Lyophilized products and Spansule Capsules, to the Egyptian market.
    • Eipico Products
      • By Alphabet
  • Biotechnology
News Details
You are here : >>News >>Press Releases >News Details
Cuba's Minister of Health visits EIPICO Factories

November 21th, 2022



 Jose Angel: Interested in cooperation with the Egyptian pharmaceutical companies

 - Dr. Olfat Ghourab: ACDIMA companies are Penetrating Latin American markets

 - Dr. Ahmed Kelani: We look forward to cooperating with biopharmaceutical companies in Cuba for joint manufacturing in EIPICO 3 factory. 


 “ Egypt possesses an advanced pharmaceutical industry , we are in Cuba interested in and encourage cooperation with the Egyptian pharmaceutical companies to provide medicines for our citizens” Mr. Jose Angel, Minister of Health of Cuba, stated

 Dr. Olfat Ghourab, the chairman of ACDIMA Company, stated , EIPICO and Medical Union Pharmaceuticals companies , its largest subsidiaries, succeeded to export their products to the Latin American markets, as it export to Ecuador, Colombia, El Salvador, the Dominican Republic and Jamaica by many medicines, the most important are insulin, and Remaist “Redismisvir”. And eye drops, and we seek collaboration with Cuba to export our products through to many countries in Latin America.

 Dr. Ahmed Kelani - Chairman and Managing Director of EIPICO Pharmaceutical Company - stated that EIPICO is looking forward to cooperating with Cuban pharmaceutical companies with great expertise in manufacturing Biosimilars & Biologicals, through technology transfer and co-manufacturing some of their advanced bio products in EIPICO 3 factory, the first in kind in MENA region that will fully manufacturing Biosimilars & Biologicals, as we done with one of the largest international companies in EIPICO 3 is scheduled to start production by the end of 2023.

 the Minister of Health of the State of Cuba, Mr. / Jose Angel, to the factories of the EIPICO Pharmaceutical Company - the largest company of ACDIMA - accompanied by the Ambassador / Tania Aguiar Fernandez, Ambassador of Cuba to Cairo, and they were received by Dr. Olfat Ghourab, Chairman of ACDIMA Company, and Dr. Ahmed Kelani, Chairman and Managing Director of EIPICO Pharmaceuticals Industries Company. Dr. Olfat gave a brief on the capabilities of ACDIMA companies and their important role in supporting the state in providing medicine, especially insulin, hormones, and medications protocols used for the treatment of COVID-19, as well as participating in all presidential initiatives in the field of health. Dr. Kelani demonstrated a presentation on EIPICO capabilities as the largest pharmaceutical company in Egypt in terms of producing medicine with more than 300 million packages annually – and ranked No 1 in local market sales , units wise, as well as the first in export, as it exports 25 % of Egyptian drug exports, and also ranked No 1 in producing & sales of antibiotics,

 Moreover, EIPICO is also ranked No 1 in sales of ophthalmic products as it’s providing the local market with 33% of its need of such products Dr. Kelani also dealt in detail with the current status of the implementation of the construction of the EIPICO 3 , Then the Cuban Minister of Health and his companions visited a number of the production departments, where he praised the advanced technological level of producing and ensuring the quality of medicines in the factory.















WE ARE EIPICO

  • Uniqueness
  • Our History
  • Vision, Mission & Values
  • Chairman Message
  • Eipico Employees

Manufacturing Facilities

  • Factory 1
  • Factory 2
  • Factory 3
  • Eiaco Factory
  • Batterjee Factory
  • Plastic Factory

Products

  • Eipico Product
  • Eipico Products By Alphabet

Contact Us

EIPICO, Tenth of Ramadan City - 1st Industrial Zone B1, Egypt.

Telephone : +20554499199
Fax : +20554499306

eipico@eipico.com.eg

Back to top
Powered by EIPICO Team
    Visitors Count : 864659